metabolic alkalosis

metabolic alkalosis
Jimmy Martenson. Frame limits and equations based off of similar figures in Hora · CC BY-SA 3.0 · source
Name	metabolic alkalosis

metabolic alkalosis is a primary acid–base disturbance characterized by an elevated arterial blood pH and a primary increase in serum bicarbonate. It arises when net acid loss or bicarbonate gain overwhelms physiologic buffering and renal compensation, producing systemic alkalemia that alters cellular function and organ systems.

Overview

Metabolic alkalosis has been described in literature associated with clinical care pathways at Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Royal Infirmary of Edinburgh. Classic teaching derives from physiologic studies by investigators at Harvard Medical School, University of Cambridge, Karolinska Institute, University of Heidelberg, and Stanford University. Treatment protocols have been incorporated into guidelines by professional organizations such as the American Thoracic Society, European Society of Intensive Care Medicine, American Society of Nephrology, Royal College of Physicians, and Society of Critical Care Medicine. Landmark reviews appear in journals including The Lancet, New England Journal of Medicine, Journal of Clinical Investigation, British Medical Journal, and Kidney International.

Pathophysiology

The pathophysiologic framework integrates renal physiology described by pioneers at University of Pennsylvania, Columbia University, Yale University, University of California, San Francisco, and University of Toronto. Bicarbonate handling involves transporters studied at Massachusetts Institute of Technology, Max Planck Society, Cold Spring Harbor Laboratory, Salk Institute, and Imperial College London. Key mechanisms include increased bicarbonate reabsorption, decreased hydrogen secretion, and volume-contraction processes delineated in experimental models from National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, and European Molecular Biology Laboratory. Hormonal modulators—aldosterone, angiotensin II, and catecholamines—have been elaborated in work from University of Oxford, Beth Israel Deaconess Medical Center, Vanderbilt University Medical Center, Karolinska University Hospital, and University College London. Cellular consequences affecting cardiac rhythm and neuromuscular function were characterized in studies from John Radcliffe Hospital, Texas Heart Institute, Children's Hospital of Philadelphia, Vanderbilt Heart and Vascular Institute, and Royal Brompton Hospital.

Causes and classification

Etiologies and classifications reflect contributions from clinical centers including Mount Sinai Hospital (New York), Toronto General Hospital, St Thomas' Hospital, Addenbrooke's Hospital, and Guy's and St Thomas' NHS Foundation Trust. Categories include chloride-responsive (volume depletion, diuretic use, vomiting) and chloride-resistant (mineralocorticoid excess, congenital disorders). Common precipitating agents and conditions have been reported in cohorts at Mayo Clinic Arizona, Sheba Medical Center, Karolinska University Hospital, Rigshospitalet, and Royal Victoria Hospital. Specific causes include prolonged nasogastric suction, laxative abuse documented in case series from Johns Hopkins University School of Medicine, M.D. Anderson Cancer Center, and Uppsala University Hospital, and endocrine disorders such as primary hyperaldosteronism characterized by work at Cleveland Clinic Foundation, Hospital Clínic de Barcelona, Santa Maria Hospital (Lisbon), and St Bartholomew's Hospital. Genetic and rare forms have been described at Children's Hospital Boston, Great Ormond Street Hospital, Sheffield Children's Hospital, and Karolinska Institute.

Clinical presentation

Symptoms and signs reported in surveillance and clinical series from University College Dublin, Harvard-affiliated hospitals, Johns Hopkins, Brigham and Women's Hospital, and Cedars-Sinai Medical Center include neuromuscular irritability, tetany, paresthesia, muscle weakness, and cramps. Cardiovascular manifestations such as arrhythmias and hypotension are documented in cardiology reports from Cleveland Clinic Heart Center, Royal Papworth Hospital, Hôpital Européen Georges-Pompidou, and Toronto General Hospital. Neurologic presentations—confusion, seizures, decreased consciousness—have been described in case reports from UCLA Medical Center, Bellevue Hospital, The Johns Hopkins Hospital, and Addenbrooke's Hospital. Physical examination findings often reflect volume status changes noted in texts produced by Oxford University Press, Cambridge University Press, Elsevier, Springer Nature, and Wiley-Blackwell.

Diagnosis

Diagnostic strategies rely on arterial blood gas analysis, serum electrolytes, and urinary studies standardized in laboratories at Mayo Clinic Laboratories, Quest Diagnostics, Eurofins Scientific, Sonic Healthcare, and ARUP Laboratories. Diagnostic algorithms build on acid–base nomograms and rules such as the Henderson–Hasselbalch equation elucidated in foundational work from University of London, University of Chicago, Princeton University, Brown University, and Duke University Medical Center. Tools for assessing urine chloride and sodium are used in clinical practice at St Vincent's Hospital, Royal Melbourne Hospital, Monash Medical Centre, and Beaumont Hospital (Dublin). Imaging and endocrine testing for secondary causes are coordinated with departments at Mayo Clinic, Cleveland Clinic, Imperial College Healthcare NHS Trust, and Karolinska University Hospital.

Management and treatment

Management principles—address underlying cause, correct volume and electrolyte disturbances, and manage complications—are reflected in protocols from National Health Service, Centers for Disease Control and Prevention, World Health Organization, American Heart Association, and European Renal Association. Interventions include isotonic saline resuscitation, potassium repletion, and cautious use of acetazolamide as practiced at Massachusetts General Hospital, Brigham and Women's Hospital, Cleveland Clinic, Royal Infirmary of Edinburgh, and St Thomas' Hospital. Mineralocorticoid antagonists and surgical approaches for endocrine causes follow guidelines from Endocrine Society, European Society of Endocrinology, and surgical teams at Mayo Clinic, Johns Hopkins Surgery, Mount Sinai Health System, and Karolinska University Hospital. Intensive care management of severe cases uses protocols from Society of Critical Care Medicine, European Society of Intensive Care Medicine, Surviving Sepsis Campaign, and tertiary centers such as Johns Hopkins Hospital, UCSF Medical Center, and Guy's and St Thomas' NHS Foundation Trust.

Prognosis and complications

Outcomes depend on etiology, comorbid conditions, and timeliness of correction, with prognostic data derived from cohort studies at Mayo Clinic, Cleveland Clinic, Johns Hopkins, Karolinska Institute, and University of Toronto. Complications include cardiac arrhythmias, neuromuscular impairment, and prolonged hospitalization, documented across registries maintained by National Institutes of Health, NHS Digital, Centers for Medicare & Medicaid Services, Australian Institute of Health and Welfare, and Canadian Institute for Health Information. Long-term sequelae are reported in follow-up clinics at Mount Sinai Hospital (New York), Royal Free Hospital, Sheba Medical Center, and St Bartholomew's Hospital.

Category:Acid–base disturbances